SALARIUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.501 USD | -5.04% |
|
+1.19% | -22.92% |
| 25/03 | Wall Street Set to Open Modestly Lower Monday Ahead of Housing, Inflation Data | MT |
| 25/03 | Top Premarket Gainers | MT |
Chart calendar Salarius Pharmaceuticals, Inc.
420739f4fbb52ca3.b7U09paxRuCeJYO0V5lRZL5jzTkhSgZPk6BVcJl9f7I.G-9yr8WJddjYSOaMMfhlLeQ6mltkf2w36uwnQOsbEegc-V3P3PoPiOdB0g~35e002e441c4347e1c0dd31392224bd9
Upcoming events on Salarius Pharmaceuticals, Inc.
Past events on Salarius Pharmaceuticals, Inc.
| 23/03/2024 01:35 am | Q4 2023 Earnings Release |
| 11/08/2023 01:35 am | Q2 2023 Earnings Release |
| 12/07/2023 | Tumor Models Conference |
| 14/06/2023 08:30 pm | Annual General Meeting |
| 08/06/2023 | European Hematology Association Hybrid Congress |
| 05/06/2023 | BIO International Convention |
| 11/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 19/04/2023 06:30 pm | American Association for Cancer Research Meeting - Abstract No 6253 |
| 16/04/2023 11:00 pm | American Association for Cancer Research Meeting - Abstract No 524 |
| 05/04/2023 08:30 pm | Diamond Equity Research Research Emerging Growth Invitational Conference |
| 27/03/2023 06:00 pm | Q4 2022 Earnings Release |
| 26/01/2023 | Molecular Glue Drug Development Summit |
| 14/12/2022 09:30 pm | Business Update Call |
| 13/12/2022 | American Society of Hematology Meeting - Abstract No 170138 |
| 13/12/2022 | American Society of Hematology Meeting - Abstract No 167495 |
| 10/11/2022 07:00 pm | Q3 2022 Earnings Release |
| 27/10/2022 03:00 am | Targeted Protein Degradation Summit |
| 06/10/2022 | American Association of Cancer Research Special Conference |
| 29/09/2022 08:00 pm | Ladenburg Thalmann Healthcare Conference |
| 08/08/2022 08:30 pm | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,47 3,32 4.37% | 5,23 5,25 -0.25% | 1,84 3,14 -41.3% | 0,00 0,00 - | 0,00 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -7,79 -8,04 3.11% | 0,00 0,00 - | 0,00 0,00 - | 0,00 | -22,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -12,8 -13,0 1.78% | 0,00 0,00 - | 0,00 | 0,00 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -7,35 -7,59 3.17% | -12,8 -13,0 1.78% | -31,6 -22,3 -41.82% | -12,5 | -21,9 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -12,5 -13,8 9.09% | -7,75 -7,50 -3.33% | 0,00 -0,85 - | -3,84 | -26,8 |
| Announcement Date | 23/03/20 | 18/03/21 | 10/03/22 | 27/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,33 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,14 -3,55 -16.92% | -5,42 -5,97 9.25% | -3,97 -4,71 15.72% | -2,53 -4,02 37% | |||||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,10 -3,71 -10.62% | -5,34 | |||||||||||
|
Net income Million USD | Released Forecast Spread | -4,10 -3,68 -11.63% | -6,11 -4,32 -41.35% | -4,72 -4,52 -4.5% | -14,4 -4,94 -191.87% | -6,37 -5,79 -10.01% | -5,34 -5,95 10.21% | -3,88 -4,69 17.26% | -2,44 -3,97 38.46% | |||||
|
EPS USD | Released Forecast Spread | -2,25 -2,00 -12.5% | -3,25 -2,25 -44.44% | -2,25 -2,50 10% | -6,41 -2,25 -184.89% | -2,75 -2,24 -22.77% | -2,23 -2,43 8.04% | -1,43 -1,30 -10.28% | -0,65 -1,34 51.31% | -6,70 | -6,70 | -6,70 | -6,71 | -5,85 |
| Announcement Date | 10/03/22 | 12/05/22 | 05/08/22 | 10/11/22 | 27/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | - | - | - | - | - |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Salarius Pharmaceuticals, Inc.
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLRX Stock
- Calendar Salarius Pharmaceuticals, Inc.